Published in Mediterr J Hematol Infect Dis on June 17, 2009
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med (1966) 7.30
Helminth infections: the great neglected tropical diseases. J Clin Invest (2008) 6.92
Rescuing the bottom billion through control of neglected tropical diseases. Lancet (2009) 6.60
Pneumocystis pneumonia. N Engl J Med (2004) 5.86
The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev (2008) 5.32
Global epidemiology of HTLV-I infection and associated diseases. Oncogene (2005) 4.77
The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol (2007) 4.09
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
Pathogenesis of infection with human immunodeficiency virus. N Engl J Med (1987) 3.45
HIV-associated lymphomas and gamma-herpesviruses. Blood (2008) 2.27
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest (2008) 2.12
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood (2006) 2.06
AIDS-related malignancies. Nat Rev Cancer (2002) 2.03
Where does HIV live? N Engl J Med (2004) 1.96
Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report. N Engl J Med (1987) 1.88
Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute. Cancer (1968) 1.80
AIDS in 1988. Sci Am (1988) 1.71
Neglected diseases, neglected technologies, neglected patients? Int J Pharm (2007) 1.69
HIV infection and lymphoma. J Clin Pathol (2007) 1.67
Malaria and the red cell. Hematology Am Soc Hematol Educ Program (2002) 1.64
West Nile virus in livestock and wildlife. Curr Top Microbiol Immunol (2002) 1.56
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.55
Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur Respir J (2005) 1.55
Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2007) 1.54
MALT Lymphomas. Hematology Am Soc Hematol Educ Program (2001) 1.50
AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol (2008) 1.28
HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog (2008) 1.22
Helicobacter pylori and Chronic ITP. Hematology Am Soc Hematol Educ Program (2008) 1.20
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematology Am Soc Hematol Educ Program (2007) 1.17
Common genetic disorders of the red cell and the 'malaria hypothesis'. Ann Trop Med Parasitol (1987) 1.15
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol (2007) 1.14
Infections in patients with hematological cancer: recent developments. Hematology Am Soc Hematol Educ Program (2003) 1.11
Infections in bone marrow transplant recipients. Clin Infect Dis (1994) 1.10
Management of infectious complications in patients with chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program (2007) 1.06
Anaemia: a useful indicator of neglected disease burden and control. PLoS Med (2007) 1.04
Viral-associated immune thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program (2008) 1.04
Epstein-barr virus and hodgkin lymphoma. Hematology Am Soc Hematol Educ Program (2007) 1.02
Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci (2001) 1.02
Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program (2001) 1.00
Infectious complications in asplenic hosts. Infect Dis Clin North Am (2001) 1.00
EpiSouth: a network for communicable disease control in the Mediterranean region and the Balkans. Euro Surveill (2009) 1.00
Viral hepatitis: manifestations and management strategy. Hematology Am Soc Hematol Educ Program (2006) 0.98
Viral infections in patients with hematological malignancies. Hematology Am Soc Hematol Educ Program (2006) 0.97
The First European Conference on Infections in Leukaemia - ECIL1: a current perspective. Eur J Cancer (2008) 0.95
Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence. Cancer (1993) 0.94
Febrile neutropenia. Ann N Y Acad Sci (2008) 0.92
A critical review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma. Curr Gastroenterol Rep (2000) 0.92
B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Autoimmun Rev (2007) 0.91
Intestinal nematode infection and anaemia in developing countries. BMJ (2007) 0.89
Status of Cytomegalovirus Prevention and Treatment in 2000. Hematology Am Soc Hematol Educ Program (2000) 0.86
Hematologic Aspects of HIV/AIDS. Hematology Am Soc Hematol Educ Program (2001) 0.86
Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Cleve Clin J Med (2008) 0.85
Infectious complications of purine analog therapy. Curr Opin Infect Dis (2001) 0.85
Fungal pneumonia due to molds in patients with hematological malignancies. J Chemother (2006) 0.85
Epstein-Barr virus--associated lymphoproliferative lesions. Clin Lab Med (1988) 0.84
Reducing the risk of blood transfusion. Hematology Am Soc Hematol Educ Program (2001) 0.83
Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy. Transpl Infect Dis (2007) 0.82
Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma. AIDS Res Hum Retroviruses (2002) 0.81
Infectious complications associated with immunomodulating monoclonal antibodies used in the treatment of hematologic malignancy. J Natl Compr Canc Netw (2008) 0.81
New concept of schistosomiasis lesions of urinary bladder versus development of bladder cancer. J Egypt Soc Parasitol (2008) 0.80
Viral lymphomagenesis. Curr Opin Hematol (2006) 0.78
Origin and evolution of HIVs and their role in AIDS pathogenesis. J Acquir Immune Defic Syndr (1988) 0.78
Imported and autochthonous histoplasmosis in Italy: new cases and old problems. Rev Iberoam Micol (2005) 0.78
Of yeasts and hyphae: a hematologist's approach to antifungal therapy. Hematology Am Soc Hematol Educ Program (2006) 0.78
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature (2010) 6.13
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res (2008) 2.52
Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin. Hepatology (2014) 2.08
Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience. Acta Neurochir (Wien) (2012) 1.99
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol (2010) 1.66
Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study. Blood (2011) 1.62
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. Int J Cancer (2008) 1.55
Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica (2008) 1.54
Mutations of the BIK gene in human peripheral B-cell lymphomas. Genes Chromosomes Cancer (2003) 1.50
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. Leuk Lymphoma (2013) 1.47
Primary plasma cell leukemia followed by testicular plasmacytoma. Int J Hematol (2011) 1.44
Endothelial progenitor cells in HIV-positive patients: what are we talking about? J Acquir Immune Defic Syndr (2013) 1.42
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci (2006) 1.31
Chordoma of the skull base: predictors of tumor recurrence. J Neurosurg (2003) 1.24
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. Blood (2007) 1.19
Role of the life span determinant P66(shcA) in ethanol-induced liver damage. Lab Invest (2008) 1.15
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett (2003) 1.15
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis. Haematologica (2009) 1.15
Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol (2002) 1.10
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer (2010) 1.07
Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Int J Cancer (2002) 1.07
Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma? Cancer Cytopathol (2013) 1.06
Is morphology alone able to predict BRAF-mutated malignancies on thyroid FNAC? Virchows Arch (2014) 1.06
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior. Prostate (2010) 1.06
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms. Blood (2011) 1.05
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis. Haematologica (2008) 1.04
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? Clin Colorectal Cancer (2011) 1.02
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha. Virol J (2010) 1.02
Telomerase inhibition impairs tumor growth in glioblastoma xenografts. Neurol Res (2006) 0.99
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome. Blood (2012) 0.98
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note. J Neurosurg (2006) 0.97
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. Neoplasia (2011) 0.97
Genome wide DNA-profiling of HIV-related B-cell lymphomas. Br J Haematol (2009) 0.97
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme. Int J Cancer (2008) 0.96
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. Cancer Cytopathol (2012) 0.93
The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation. Int J Cancer (2012) 0.93
Congenital tumors of the retrorectal space in the adult: report of two cases and review of the literature. Tumori (2008) 0.92
Soft tissue non-Hodgkin lymphoma of shoulder in a HIV patient: a report of a case and review of the literature. World J Surg Oncol (2008) 0.91
Paediatric Kikuchi-Fujimoto disease: a benign cause of fever and lymphadenopathy. Pediatr Blood Cancer (2008) 0.91
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease. Ann Clin Lab Sci (2005) 0.90
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J Infect (2006) 0.89
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases. Int J Cancer (2008) 0.89
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma. Am J Clin Pathol (2012) 0.89
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. Mediterr J Hematol Infect Dis (2010) 0.88
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. Leuk Res (2009) 0.88
Role of PTEN in gastrointestinal stromal tumor progression. Arch Pathol Lab Med (2004) 0.87
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas. Br J Haematol (2011) 0.87
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. Leuk Lymphoma (2007) 0.87
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma. AIDS (2010) 0.86
Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment. Antimicrob Agents Chemother (2013) 0.86
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. Cancer (2012) 0.86
Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis. Am J Pathol (2005) 0.85
Quality of life, depression, and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. Clin Invest Med (2009) 0.85
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord. Neurol Res (2006) 0.84
Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid-based biopsies of thyroid neoplasms suspicious for carcinoma. Eur J Endocrinol (2013) 0.84
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. J Med Virol (2013) 0.84
Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma. Pancreas (2010) 0.84
Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature. Haematologica (2006) 0.84
Glioblastoma induces vascular endothelial cells to express telomerase in vitro. Cancer Res (2003) 0.82
Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts. Int J Cancer (2006) 0.82
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. Curr HIV Res (2010) 0.81
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. Leuk Lymphoma (2011) 0.81
Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma. AIDS Res Hum Retroviruses (2002) 0.81
Dysregulated expression of Bcl-xL in CD34+ cells isolated from patients with refractory anemia with excess of blasts during megakaryocytic differentiation. Haematologica (2002) 0.81
Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients. Inflamm Bowel Dis (2011) 0.80
Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Transl Oncol (2010) 0.80
Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection. J Med Virol (2008) 0.80
Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients? Haematologica (2008) 0.80
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. J Med Virol (2010) 0.80
Cervical extramedullary lymphomatoid granulomatosis. J Clin Neurosci (2011) 0.80
Systemic granulomatous reaction secondary to treatment of bladder cancer with bacillus calmette-guerin. Mediterr J Hematol Infect Dis (2012) 0.79
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report. Clin J Pain (2002) 0.79
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. J Acquir Immune Defic Syndr (2003) 0.79
Inguinal lymphadenopathy due to Bartonella henselae. Infez Med (2008) 0.79
Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. J Clin Oncol (2002) 0.79
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. Ann Clin Lab Sci (2006) 0.78
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma. Hematol Oncol (2012) 0.78
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: a cytohistologic institutional experience. Cancer Cytopathol (2014) 0.78
Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people. Thromb Res (2013) 0.78
Combined Modality Treatment Including Methotrexate-Based Chemotherapy For Primary CENTRAL Nervous System Lymphoma: A Single Institution Experience. Mediterr J Hematol Infect Dis (2009) 0.77
In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicin. J Acquir Immune Defic Syndr (2002) 0.77
Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience. Cancer Cytopathol (2014) 0.77
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias. Clin Invest Med (2007) 0.77
Small lymphocytic lymphoma in a patient with Fabry disease. Leuk Lymphoma (2012) 0.77
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. Haematologica (2006) 0.76
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin. Neoplasia (2013) 0.76
Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome? Clin Gastroenterol Hepatol (2009) 0.76
High dose of erythropoietin in management of interferon/ribavirin induced anemia. Hepatogastroenterology (2007) 0.76
Blood and endothelial cells: together through thick and thin. Blood (2013) 0.75
Does "more" necessarily mean "better"? Blood (2012) 0.75
Mantle cell lymphoma relapsing at the lymphedematous arm. Mediterr J Hematol Infect Dis (2013) 0.75
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3. Mediterr J Hematol Infect Dis (2012) 0.75
Simultaneous presentation of Waldenstrom's macroglobulinemia and acute myeloid leukemia. Haematologica (2002) 0.75
[Retroperitoneal Castleman's disease. A report of two cases and analysis of the literature]. Chir Ital (2007) 0.75
The mutant JAK2 allele burden in children with essential thrombocythemia. Br J Haematol (2009) 0.75
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. J Clin Oncol (2008) 0.75
Short communication: proangiogenic hematopoietic cells in acute HIV infection. AIDS Res Hum Retroviruses (2013) 0.75
Granulomatous cheilitis in an HIV positive patient on HAART therapy. Eur J Dermatol (2008) 0.75
Optimization of comorbidity therapy to achieve sustained viral response in HCV patients. Hepatogastroenterology (2012) 0.75
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. Blood (2002) 0.75